Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. van Doorn R, Nijland PG, Dekker N, Witte ME, Lopes-Pinheiro MA, van Het Hof B, Kooij G, Reijerkerk A, Dijkstra C, van van der Valk P, et al. Acta Neuropathol. 2012 Jul 19. Epub 2012 Jul 19. PMID: 22810490. Abstract CommentRecommendBookmarkWatch